T he differentiation and maturation of immature transitional B cells of the marrow into mature but naive B cells requires the coordinated expression of a number of gene products (1) . Pax5 and the E2 transcriptional regulators are widely regarded as central for inducing the expression of many of the early B cellspecific products (such as CD19 and IgM) in maturing marrow B cells (2, 3) . Later, as B cells enter the periphery, additional transcription factors, such as Mef2c, NF-kB family members, NFAT proteins, Ciita, and Notch signaling family members, continue the differentiation of immature B cells into mature follicular (FO) or marginal zone (MZ) cells (4, 5) . A number of studies have sought to define the key transcriptional regulators and kinetics that control this pathway. In one such analysis, we examined the expression of transcriptional regulators during B cell differentiation, comparing B220 + B cells obtained from the marrow of 2-wk-old animals (thus lacking mature recirculating B cells), from spleens of 2-wk-old animals [enriched for transitional 1 (T1) and transitional 2 (T2) B cells], and from mature but naive spleens (enriched for FO and MZ B cells) (6) . That gene expression screen identified a number of candidate transcriptional regulatory proteins whose expression increased with B cell maturation. Zfp318 was one such factor.
The Zfp318 gene encodes a primary protein of 2237 aa that includes domains encoding two C 2 H 2 zinc fingers and a myosin IIhomology sequence as well as regions rich in serine and basic amino acids (7, 8) . A smaller truncated form of Zfp318 has also been described in the mouse, but only the full-length form has been found as a homolog in human tissues. Zfp318 has been most extensively studied in the testes (an alternative name for the protein is testicular zinc-finger, or TZF) where it is expressed during spermatogenesis. In transfection analyses, Zfp318 was shown to augment ligand-dependent androgen receptor (AR) control in a dose-dependent fashion (9) . The possibility that Zfp318 could also play a role in B cell development via the AR was suggested by a number of studies showing B cell functions dependent upon AR (10, 11) . In one such study, using a B cellspecific deletion of AR, B cell development from the marrow was inhibited, accompanied by enhanced autoimmune responses, using a collagen-induced arthritis model (12) .
To determine if Zfp318 does have a role in the development and function of B cells, we created a mouse with a conditional (Flox'd) deletion of the gene. Using Vav-Cre-dependent deletion of the gene, we have found that B cells deficient in Zfp318 developed from marrow precursors virtually identical to that of wild type (WT). Zfp318-deficient, naive splenic B cells did, however, demonstrate a dramatic loss of both IgD-specific transcripts and protein. IgM and IgD are synthesized from alternatively spliced transcripts positioning the same VDJ domains on either the IgM or the IgD constant domains (13, 14) . The gene sequences encoding the IgM transcripts have been denoted Ighm, whereas those encoding IgD are identified as Ighd. The loss of IgD in the Zfp318-deficient B cell was due to the nearly exclusive use of Ighm transcripts to produce the IgM product owing to RNA transcript termination prior to the IgD-encoding exons. The role of Zfp318 in regulating gene products is highly specific for IgD, in that genome-wide transcriptome analysis of B cells obtained from the Zfp318-deficient animal identified only a single additional gene with significantly altered gene expression.
As our data were being prepared for submission, a report by Enders et al. (15) detailed the results of an ethylnitrosourea mutagenesis screen followed by whole-exome sequencing that identified a single point mutation (a nonsynonymous T . C transition altering the protein sequence I1347T) within Zfp318 that inhibited the production of IgD. This mutation mapped to the long form of the protein, confirming its necessity versus that of the alternatively spliced, truncated form of the protein. The group also created a germline Zfp318 null animal by gene targeting that reproduced their point mutation analyses. Those data, along with the findings presented in this article, confirm the necessity of Zfp318 for the production of IgD.
Materials and Methods

Animal strains and care
Animals were housed in the Animal Resource Center (University of Utah Health Science Center, Salt Lake City, UT) according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All animal protocols were reviewed and approved by the University of Utah Institutional Animal Use and Care Committee. For transcriptional profiling experiments, C57BL/6 mice were bred and maintained in house. B6.Cg-Tg (Vav1-cre)A2Kio/J mice (Stock #008449) were obtained from The Jackson Laboratory and maintained as heterozygotes. Zfp318
Fl/Fl mice were bred to the Vav-Cre deleter strain to obtain progeny with a hematopoietic-specific deletion of Zfp318 [conditional knockout (cKO)]. Littermates approximating 4 wk of age were used for all experiments. Numbers of animals used per experiment are noted in the figure legends.
Generation of the Zfp318
Fl/Fl animal 
FACS analysis and sorting of hematopoietic cell populations
Upon dissection, the plunger of a 5-ml syringe was used to dissociate thymus and spleen tissues. Cells were strained through a 100-mm filter and collected in 10 ml FACS buffer (13 PBS + 0.1% BSA). Bone marrow was collected from both femurs and tibias. Removing the ends of each bone with a razor blade exposed bone cavities. Marrow was flushed from cavities using a 5/8-inch 25-gauge syringe and FACS buffer. Contents were collected in 8 ml FACS buffer. After centrifugation, erythrocytes were lysed on ice for 10 min using ACK buffer. Following lysis, cells were respun, resuspended in FACS buffer, and counted using a hemocytometer. Cells were stained on ice for 30 min using the appropriate Ab mixture. Samples were washed with FACS buffer, centrifuged, and resuspended in FACS buffer. To discriminate between live and dead cells, DAPI was added at a final concentration of 3 mm. The Abs used with their indicated dilutions are available in Supplemental Table I . Population analysis was performed on the FACSCanto II (BD Biosciences), and results for a given cell type are graphically represented as mean values 6 SEM of total live cells or ratios of live cells analyzed per tissue. Cell sorting of select populations was performed on the Aria Cell Sorter (BD Biosciences) at the University of Utah Flow Cytometry Core.
Analysis of whole blood cell populations
Blood was collected in heparinized capillaries via the retro-orbital route. Complete blood counts were obtained using a Hemavet 950 FS (Drew Scientific). Results for a given parameter are listed in Supplemental Table II and are represented as mean values 6 SEM.
RNA-sequencing analysis
A total of 5 3 10 5 splenic CD19 + B cells were FACS sorted from three WT and three Zfp318 cKO mice. Total RNA was isolated as described above. A total of 50 ng total RNA was used for RNA-sequencing (RNA-Seq) library preparation, using the Illumina TruSeq RNA Sample Preparation kit with the polyA enrichment step omitted. Libraries were subjected to HiSeq2000 50 Cycle Single Read Sequencing. Greater than 20 3 10 6 reads per sample were obtained and aligned to the mm10 (Ensembl build 75) transcriptome index, using Novoalign. Aligned reads were further processed for splicing and expression variance with the UsEquation 8.7.4 software package. Data tracks were visualized with the University of California-Santa Cruz genome browser.
Statistical analysis
For FACS, RT-PCR, and complete blood count data, two-tailed unpaired Student t tests were applied for all relevant statistical comparisons, using GraphPad Prism software. For RNA-Seq analysis, two-tailed Student t tests using two-sample equal variance were performed with Microsoft Excel. Statistical cutoffs are noted in the figure legends.
Results
Analysis of Zfp318 expression, the generation of a Zfp318-deficient animal, and analysis of B cell development in the absence of Zfp318
Our previous screen of maturing and mature B cells for the expression of Zfp318 used gene grid array analysis of pooled age-and tissue-specific B cells (6) . To expand and specify the time frame of Zfp318 expression during B cell development, we FACS sorted and isolated pro, pre, and newly formed (NF) B cells from the bone marrow, and T1, T2, MZ, and FO B cells from the spleen (Supplemental Fig. 1 ). RNA was extracted and analyzed for Zfp318-specific transcripts. As shown in Fig. 1A , the presence of the Zfp318 transcript parallels the maturity of the cell, similar to our previous observation. Of interest, although the FO cells showed the highest level of expression, the MZ cells had dramatically less Zfp318 transcript, similar to levels seen in the NF marrow population.
To create a conditional Zfp318-deficient animal, we generated a targeting construct that possessed a LoxP site upstream of the transcriptional start site and a second LoxP site ∼7000 bp 39 (Fig. 1B) . Deletion of the sequences between the two LoxP sites would thus remove the promoter sequences, the initiating ATG, and the first two coding exons of the gene. This construct was used to create a germline-targeted animal, which was then bred to the Vav-Cre deleter line (maintained as a heterozygote). Genotyping of this animal (Fig. 1C) for the WT and flox'd/knockin alleles was done using PCR primers specific for the products and DNA isolated from either the tail or the bone marrow of heterozygote (WT/fl) or homozygous Zfp318-targeted animals (fl/fl) with or without the Vav-Cre deleter transgene. With use of the P1 and P2 PCR primers, the 175-bp fragment of WT DNA is evident, as is the same sequence containing the inserted LoxP site in the tail of the heterozygote and KO. However, that sequence is entirely lost in the marrow of the KO animal possessing the Vav-Cre construct, indicating a very efficient deletion of those sequences in the tissue expressing the Vav-Cre transgene. The loss of Zfp318 expression was confirmed and quantified in the spleen of the cKO compared with that of WT (Fig. 1D ), using the primers described in Supplemental Table I (4913/4914 ).
The development of B cells in the cKO animal was analyzed. The percentage of CD19 + cells and quantification of total cells of the marrow ( Fig. 2A) were assessed using markers to define the pro, pre, NF, and mature, recirculating B cells (CD22 + AA4.1 2 ) in 4-wk-old animals. No significant difference was noted between the WT and cKO marrow samples. A similar analysis was carried out using the T1, T2, MZ, and FO populations of the spleen (Fig. 2B) . Again, the cKO animals closely tracked with WT animals, except for a slight but significant depression in T2 B cells in the cKO animals. Hemavet analysis of peripheral blood also showed no Table I ). The Zfp318 fl/fl (Zfp318 KN) allele is deleted only in cells isolated from the bone marrow, demonstrating the hematopoietic specificity of gene deletion. (D) Loss of Zfp318 transcripts was validated using cDNA derived from WT and cKO total spleen tissues. Three biological replicates were performed per genotype. For (A) and (D), Zfp318 transcripts were normalized to Actb, and data are represented as the mean 6 SEM. ND, not detected. The Table II ).
The absence of Zfp318 results in the loss of IgD
The previous analyses indicated that the development of mature B cells in the cKO animal was very similar to that of WT, but did not determine if the lack of Zfp318 altered the expression of B cell gene products. As a primary screen, we analyzed the cKO splenic B cells for the expression of mature marker proteins such as CD35, CD21, B220, and CD19 and found expression levels of these proteins to be indistinguishable from those of WT (Fig. 3A-C) . When assaying for the expression of IgM and IgD, the two Igs expressed by mature naive B cells, we were surprised to find the level of IgM elevated in the cKO animals compared with WT. As shown in Fig. 3D , cells from the cKO animal (gray filled plot) expressed significantly higher levels of IgM than did either WT or the Zfp318 cKO heterozygote animal in the T2 and FO populations. The analysis of IgD expression demonstrated the complete lack of IgD surface protein on cells of T1, T2, MZ, and FO populations compared with WT and heterozygote animals (Fig. 3E ). The differences in expression levels of IgM and IgD were quantified by analysis of mean fluorescence intensity (MFI) in the WT and cKO populations (Fig. 3F) . The elevated level of expression of IgM in the cKO cells was significantly different from that of WT in the T2, FO, and MZ populations, whereas the loss of IgD in the T1, T2, FO, and MZ populations was significantly different in the cKO samples.
Both IgM and IgD are encoded from a single heterogeneous nuclear RNA (hnRNA) transcript via alternative splicing of the VDJ sequences to those exons encoding the C region domains. To determine if these differences in surface expression of IgD and IgM on the surface of Zfp318-deficient B cells were reflected in transcripts specific for the IgM and IgD products, quantitative RT-PCR was performed using RNA obtained from total spleen (WT and cKO) and analyzed using primers specific for the IgM (Ighm) and IgD (Ighd) constant regions. As shown in Fig. 3G , the level of IgM transcripts trended higher in the cKO animal, whereas those encoding IgD in the cKO animal were reduced .90% compared Table III) . On the left, log 2 fold change per gene between WT and cKO samples is plotted against the p value. On the right, WT and cKO FPKM are plotted for all genes analyzed. Genes were considered significantly altered with a log 2 fold change . The Journal of Immunologywith WT. These data, in total, suggest that the absence of the Zfp318 protein does not alter the transcriptional activity of the locus encoding the IgM and IgD proteins, but does alter the relative proportion of transcripts destined to encode the IgM and IgD proteins.
The absence of Zfp318 blocks IgD production by transcriptional termination at the end of the IgM-encoding exons
The loss of IgD-encoding transcripts (and IgD protein) in the absence of Zfp318 suggested this protein alters transcript quantities. To determine if this effect was unique to that of IgD, we performed RNA-Seq using RNA obtained from purified CD19
+ splenic B cells from three WT and three cKO animals (Supplemental Table III ). Analysis of those data indicated that only three gene products showed significantly altered expression in the cKO animals: the Zfp318 gene itself; the region of the Ighm/ Ighd locus encoding the IgD protein; and Sva, a gene on mouse chromosome 6 that encodes a "seminal vesicle Ag" unique to mice (Fig. 4A) . RNA-Seq data from three genes are shown (Fig.  4B-E) , using one representative WT and cKO sample. As expected, Zfp318 transcripts are absent in the cDKO (Fig. 4B) , the Cr2 gene products (which produce the Cr1 and Cr2 proteins via alternative splicing) are identical between the two samples (Fig.  4C) , and the Ighm and Ighd loci show IgM-specific transcripts in both WT and cKO, but absence of IgD-specific transcripts in the cKO animal (Fig. 4E) 
The loss of IgD-encoding transcripts in the cKO B cells could be due to at least two mechanisms: blocking the alternative splicing of the IgM-and IgD-encoding transcripts, or blocking the hnRNA transcription of the Ighm locus to the sequences encoding the IgD protein. The Ighm/Ighd locus contains at least three distinct transcriptional stop sites, including one just 39 of the exons encoding secreted IgM, a second site allowing for the production of membrane bound IgM, and a third site 39 of the last exon encoding the mature, membrane-bound IgD protein (16) (17) (18) (19) . To encode both IgM and IgD via alternative splicing of hnRNA, the transcriptional stop sites linked to the IgM-encoding exons must be ignored by the Pol II RNA polymerase complex. A close analysis of the RNA-Seq data obtained from the Ighm/Ighd locus revealed a dramatic loss of virtually all RNA transcripts 39 of the IgM-encoding exons (Fig. 5A) , suggesting that production of hnRNA containing the IgD-encoding sequences was significantly reduced in the absence of Zfp318.
The production of Ighm/Ighd hnRNA in the cKO animal was further quantified by RT-PCR analysis of intronic sequences from IgM-encoding and IgD-encoding regions of the locus. Two primer sets (Fig. 5A ) were used to screen total RNA via RT-PCR. The first primer set (primer set A) included an IgM-specific intronic sequence and a turnaround within the last exon of the IgM region, Left, For each sample, Ct-derived transcript ratios of Set B/Set A were generated. The mean WT value was used to derive the "percentage of WT" for each individual sample (e.g., WT-1/WT-mean or cKO-1/WT-mean). **p , 0.01. Right, Amplification products from a Cd3« upstream noncoding intergenic region (top) and from a region internal to IgM-specific exon 6 (Set C) (bottom).
whereas the second set of primers (primer set B) was 39 of the Ighm transcriptional stop site to generate membrane-bound IgM. The relative products from these two sets of primers were quantified (Fig. 5B) by establishing a ratio of the IgD-intronic sequence (primer set B) versus the IgM-intronic sequence (primer set A). Clearly, there is a marked change in ratio of these intronic sequences comparing the WT with the cKO samples (70% reduction in the cKO). RT-PCR analyses of RNA samples can be clouded by the presence of genomic DNA. To control for this, triplicate WT and cKO RNA samples (and genomic DNA as control) were analyzed using primers specific for a region of the Cd3« gene that is not transcribed, and using an oligo set within the final coding exon of the IgM protein (primer set C) (Fig. 5A) . The cDNA samples obtained from the WT and cKO RNA samples did not demonstrate amplification of the Cd3«-associated sequences but did show equal quantities of the Ighm gene product (Fig. 5B) , indicating that amplification of genomic sequences from the IgMand IgD-encoding regions of the Ighm locus was from hnRNA, not genomic DNA.
Discussion
Naive FO cells express both IgM and IgD, whereas MZ cells preferentially express IgM (Fig. 6 B, C) . Expression of Ighd in naive maturing B cells closely parallels that of Zfp318 ( Currently, very little is known about what regulates the differential expression of transcripts coding for IgM and IgD via alternative splicing of a common VDJ region to the IgM-or IgDencoding exons. Indeed, the best parallel to this system may be in the analysis of the U1A-mediated regulation of membrane versus secreted IgM. Similar to Zfp318, U1A expression levels are regulated throughout B cell development/differentiation, with high expression being required for the repression of secretory IgM (20) . U1A acts to block the expression of secretory IgM by impairing the binding and, hence, downstream function of the polyA cleavage complex, which includes CPSF (cleavage and polyadenylation specificity factor), Cstf, and polyA polymerase (20) (21) (22) (23) . U1A mediates this suppression by interacting with multiple nonconsensus U1A binding sites (AUGC-core) both upstream and downstream of the AAUAAA polyA signal. Owing to the nature of these binding sites, a mass action effect of U1A is required to achieve full repression. A similar scenario may be true for the function of Zfp318, as high Zfp318 gene expression levels correlate with high Ighd levels in various B cell populations (Fig. 6 ). Similar to the secretory IgM polyA site, three AUGC sites are clustered ∼500 bp upstream of the membrane IgM polyA signal. Whether these binding sites are functional for Zfp318 recognition remains to be determined. However, Zfp318 does possess multiple U1-RNA zinc finger domains; thus, it is tempting to speculate that Zfp318 regulates Ighm/Ighd gene transcription by binding to these AUGC sites. An alternative possibility is that Zfp318 may interact with a yet-to-be-determined binding site(s) and serves to stabilize the binding of U1A, leading to a more stable repression of polyA usage. This idea is partially supported by data in Fig. 5 , showing the 70% loss of transcription downstream of the membrane IgM polyA signal rather than a complete block upon Zfp318 deletion.
Our analysis of Zfp318-deficient B cells shows that the absence of IgD expression is linked to the preferential usage of a transcriptional stop site located within the final Ighm exon, thus blocking synthesis of the full Ighm/Ighd hnRNA, which is required for the production of IgD (Fig. 6D) (16, 18) . This finding implicates the Zfp318 protein as functioning to block recognition of the IgM-specific transcriptional stop site, allowing for the RNA Pol II complex to proceed down the chromosome into the IgDencoding region. This finding suggests that Zfp318, which possesses two putative nucleic acid-binding zinc finger domains (7), recognizes the IgM-specific transcriptional stop site and inhibits transcription termination at that site, possibly by inhibiting RNA pausing and transcription termination via the CPSF protein complexes or those required for cleavage (24) (25) (26) . It also suggests that the regulation of Zfp318 is intimately tied to B cell differentiation (MZ B cells express low levels of both Zfp318 and IgD, whereas FO cells express much higher levels of both gene products) and that FO B cell activation, which results in the loss of IgD (but expression of IgM), may also regulate the expression of Zfp318.
We know of no other instance in mammalian cells in which a transcription stop site is blocked, in a similar fashion to what we see for the Ighm locus, to allow for the production of a longer hnRNA molecule and increased genetic capacity. The IgM-encoding region of Ighm also possesses a transcription stop site that generates the smaller, secreted form of the protein that must also be ignored by the Pol II complex in the naive B cell. This site is not blocked by Zfp318; if it were, we might have expected only secreted IgM in the absence of Zfp318. However, whether this second site is blocked by another protein functioning in an analogous fashion to Zfp318 is not known.
The expression of Zfp318 parallels that of other transcriptional regulators during the maturation and development of B cells. One such regulator, Mef2c, also demonstrates enhanced expression in FO cells compared with MZ cells. Our previously published analysis of Mef2c-deficient B cells demonstrated a dramatic reduction in expression of Zfp318 (27) . This reduction in Zfp318 expression, however, was not to the same magnitude as a Zfp318 gene deficiency. Indeed, B cells lacking Mef2c still express IgD (28) , suggesting that sufficient Zfp318 was present to allow for Ighd transcription.
The analyses of our Zfp318 deficiency via Vav-Cre phenocopies the results described by Enders et al. (15) , although a relative depression of T2 B cells of the spleen was not noted in their report. Enders et al. further suggested that Zfp318 served to regulate IgD production by controlling the alternative splicing of the hnRNA of the Ighm/Ighd locus, although no data were presented to support this model (15) . Our conclusions regarding the proposed function of Zfp318 differ from those presented by Enders et al. because of our RNA-Seq data, which point to the regulation of transcription termination as the event that subsequently allows for the production of IgD via alternative splicing. Thus it is the primary production of the Ighm/Ighd hnRNA that is the key step regulated by Zfp318, not the alternative splicing choice of the VDJ sequence to either the IgM-or the IgD-encoding exons.
